Non-Traditional Clinical Trial Sites Powered by the Curebase System Support Emergency Use Authorization of New Rapid COVID-19 Test

Andi Seymour brings over 15 years of progressive and hands-on experience to Curebase as the newly appointed VP of People.

Curebase and Portamedic announce ongoing partnership to collect blood samples and other tests from participating decentralized clinical trial patients' homes throughout the U.S

Scott Garcia brings 15+ years of experience scaling high-growth companies to Curebase as new VP of Finance

Curebase and Flow Neuroscience - the creator of Europe's first medically approved portable transcranial direct current stimulation (tDCS) device - investigate a digital therapeutic for reducing depressive symptoms.

Lars-Olof "Lollo" Erkisson, Head of Clinical Development at Infant Therapeutics AB, brings cross-continental clinical operations expertise to Curebase Advisory Board

Curebase recognized by Fast Company's 2022 World Changing Ideas Awards for decentralized, patient-centric trial model

Part 2 of Note to File Podcast with Brad Hightower featuring Jane Myles, VP of Clinical Trial Innovation at Curebase

Curebase and Vicore Pharma partner on IPF mental health digital therapeutic study

Curebase featured as decentralized clinical provider optimizing digital processes for patient safety and scientific advancement

Jane Myles, VP of Innovation at Curebase, discusses how DCTS play a role in improving health equity

Jane Myles appears on Note to File Podcast with Bradley Hightower to discuss all things DCT

Curebase hires its 100th teammate within six months of raising Series A financing

Curebase is partnering with Blue Note Therapeutics on a fully virtual study comparing the effectiveness of two PDTs on the mental and physical health of cancer patients who recently or are currently undergoing treatment

Curebase launching study in Italy and France with a lab from the University of Côte d'Azur to improve the quality of life for elderly people

Curebase welcomes Dr. Amir Lahav, leading digital health innovator, and Dr. Aaron Kamauu, leading real-world data expert, to new Advisory Board

Curebase will work closely with Society for Clinical Research Sites to advance site engagement and sustainability

Digital technology has had such a deep and profound impact on healthcare that it has spawned a new term – digital health – and an industry with multiple stakeholders, including clinicians, consumers, software and hardware vendors, labs, scientists, researchers and public health officials.

Tom Lemberg, founder and CEO of Curebase, talks all things BYOP (Bring Your Own Physician) on the latest episode of Empowered Patient Podcast with Karen Jagoda

Healthcare IT Today features predictions from Tom Lemberg, founder and CEO of Curebase, on diversity in clinical research

Curebase founder and CEO, Tom Lemberg, discusses the future of patient-centric decentralized clinical trials, including the Bring Your Own Physician (BYOP) model

Curebase and Persephone, collaborating with Janssen Research & Development, announce study to develop prevention strategies and better treatment options for colorectal cancer (CRC) with focus on participant diversity

Curebase Earns Top 100 on Built In's Best Remote-First Companies to Work for in 2022

Decentralized clinical trial company brings expertise in remote studies to large industry group devoted to improving trial quality

Curebase serves as technology and #decentralizedtrial execution partner for MetaMe Health's digital therapeutic, Regulora®, the first FDA-authorized treatment of any kind specifically for abdominal pain associated with irritable bowel syndrome (IBS)

Curebase recognized for achievements in Clinical Trials Tech

Curebase CEO offers expert insight into the dawn of dynamic clinical trial designs

Founder and CEO of Curebase receives Forbes 30 Under 30 prestigious honor for leading positive, global change in healthcare

Edesa Biotech using new Curebase feature for enhanced telemedicine on our eClinical platform that allows providers to view, measure, and record patient symptoms via the built-in application

Decentralized clinical trial to leverage Curebase software platform, Veterans' advocacy groups

Curebase and Checkable Medical launch first-ever at-home strep test decentralized clinical trial

Curebase and DTA partner to develop a joint white paper to provide clinical trial regulatory guidance and best practices for DTx clinical evidence generation

Curebase's decentralized clinical trial approach helps secure FDA Emergency Use Authorization for InBios' new COVID-19 IgG Antibody Rapid Test, one of many instances where Curebase's model has successfully supported EUA for diagnostic tests during the pandemic

Katri Langel, international IT and clinical research expert, joins Curebase as Senior Director of Program Development for Europe

Curebase names clinical trials veteran, Wayne Bowden, as Vice President of Business Development to lead new growth and expansion efforts

AppliedVR will test its virtual-reality-based digital therapeutics across five studies using the decentralized clinical trials software from Curebase

Curebase, a company committed to democratizing access to clinical studies through decentralized clinical trials, has named tenured clinical research expert Jane Myles as vice president of clinical trial innovation

Initial study will validate effectiveness of Adaptive's Lyme disease immune detection test

The company Curebase is promoting the concept of 'bring-your-own-physician' clinical trials.

Industry veteran brings more than two decades of success building healthcare companies

Curebase featured in Wall Street Journal among startups realizing venture capital boom in digital health

Study demonstrates efficacy of InBios diagnostics test, Curebase decentralized trials platform

Curebase has raised a $15 million series A for a new approach to decentralized trials that goes beyond the current drop of virtual trial platforms.

Cofactor Genomics said Tuesday that it has commenced the first multicenter clinical trial of its OncoPrism immunotherapy response prediction assay, an RNA-based test developed using the company's proprietary immune modeling technology.

Operationalizing drive-through COVID testing locations as clinical research sites provided a safe and convenient way to enroll and consent potential participants in key diagnostic validation study

UK biotech Closed Loop Medicine (CLM) has started recruiting patients into a trial that will test whether a drug linked to a smartphone app can improve treatment for hypertension.

Tobacco smoking remains the leading cause of preventable death and disease worldwide. Digital interventions delivered through smartphones offer a promising alternative to traditional methods, but little is known about their effectiveness.

Curebase launches the CURE-19 Platform to provide a resource for researchers seeking to better understand COVID-19 as the pandemic begins